The Role of Microtubules in Heart Failure
Main Article Content
Abstract
Heart failure (HF) is a complex pathological state in which cardiac performance fails to match perfusion demand, commonly preceded by an enlargement of the heart known as cardiac hypertrophy. Pathological changes in the microtubule network (MTN) organization have been shown to increase cellular stiffness and lead to contractile dysfunction of cardiomyocytes. In this narrative review, we are focusing on the role of the microtubule and also its mechanism in the heart, especially in HF. We conducted literature research for published articles carried out from 2012 to 2022. Microtubules are polymers that serve as structural elements with the shape of long, rigid tubes that are highly dynamic. The stiffness of the myocardium is largely influenced by the MTN. Through various methods, the MTN is remodeled during cardiac hypertrophy and HF. Targeting microtubules for the treatment of HF might become a new approach to improve the outcome. While colchicine inhibits various microtubule-dependent cellular in interphase cells and proliferation, it needs further study for the safety of the adjusted dosage. Manipulating detyrosination of microtubules might be useful for restoring the function of failing myocytes although there are still very limited data on this.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Li JM, Yao ZF, Zou YZ, Ge JB, Guan AL, Wu J, et al. The therapeutic potential of G-CSF in pressure overload induced ventricular reconstruction and heart failure in mice. Mol Biol Rep. 2012;39(1):5-12. https://doi.org/10.1007/s11033-011-0703-8 PMid:21431359
Phyo SA, Uchida K, Chen CY, Caporizzo MA, Bedi K, Griffin J, et al. Transcriptional, post-transcriptional, and post-translational mechanisms rewrite the tubulin code during cardiac hypertrophy and failure. Front Cell Dev Biol. 2022;10:837486. https://doi.org/10.3389/fcell.2022.837486 PMid:35433678
Caporizzo MA, Chen CY, Bedi K, Margulies KB, Prosser BL. Microtubules increase diastolic stiffness in failing human cardiomyocytes and myocardium. Circulation. 2020;141(11):902-15. https://doi.org/10.1161/circulationaha.119.043930 PMid:31941365
Borin D, Peña B, Chen SN, Long CS, Taylor MR, Mestroni L, et al. Altered microtubule structure, hemichannel localization and beating activity in cardiomyocytes expressing pathologic nuclear lamin A/C. Heliyon. 2020;6(1):e03175. https://doi.org/10.1016/j.heliyon.2020.e03175 PMid:32021920
Caporizzo MA, Prosser BL. The microtubule cytoskeleton in cardiac mechanics and heart failure. Nat Rev Cardiol. 2022;19(6):364-78. https://doi.org/10.1038/s41569-022-00692-y PMid: 35440741
Goldblum RR, McClellan M, White K, Gonzalez SJ, Thompson BR, Vang HX, et al. Oxidative stress pathogenically remodels the cardiac myocyte cytoskeleton via structural alterations to the microtubule lattice. Dev Cell. 2021;56(15):2252-66.e6. https://doi.org/10.1016/j.devcel.2021.07.004 PMid:34343476
Chen CY, Caporizzo MA, Bedi K, Vite A, Bogush AI, Robison P, et al. Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure. Nat Med. 2018;24(8):1225-33. https://doi.org/10.1038/s41591-018-0046-2 PMid:29892068
Caporizzo MA, Chen CY, Prosser BL. Cardiac microtubules in health and heart disease. Exp Biol Med (Maywood). 2019;244(15):1255-72. https://doi.org/10.1177/1535370219868960 PMid:31398994
Gudimchuk NB, McIntosh JR. Regulation of microtubule dynamics, mechanics and function through the growing tip. Nat Rev Mol Cell Biol. 2021;22(12):777-95. https://doi.org/10.1038/s41580-021-00399-x PMid:34408299
Roll-Mecak A. The tubulin code in microtubule dynamics and information encoding. Dev Cell. 2020;54(1):7-20. https://doi.org/10.1016/j.devcel.2020.06.008 PMid:32634400
Zwetsloot AJ, Tut G, Straube A. Measuring microtubule dynamics. Essays Biochem. 2018;62(6):725-35. https://doi.org/10.1042/EBC20180035 PMid:30287587
Sirajuddin M, Rice LM, Vale RD. Regulation of microtubule motors by tubulin isotypes and post-translational modifications. Nat Cell Biol. 2014;16(4):335-44. https://doi.org/10.1038/ncb2920 PMid:24633327
Scriven DR, Asghari P, Moore ED. Microarchitecture of the dyad. Cardiovasc Res. 2013;98(2):169-76. https://doi.org/10.1093/CVR/CVT025 PMid:23400762
Vega AL, Yuan C, Votaw VS, Santana LF. Dynamic changes in sarcoplasmic reticulum structure in ventricular myocytes. J Biomed Biotechnol. 2011;2011:382586. https://doi.org/10.1155/2011/382586 PMid:22131804
Gross P, Johnson J, Romero CM, Eaton DM, Poulet C, Sanchez- Alonso J, et al. Interaction of the joining region in junctophilin-2 with the L-type Ca2+ channel is pivotal for cardiac dyad assembly and intracellular Ca2+ dynamics. Circ Res. 2021;128(1):92-114. https://doi.org/10.1161/CIRCRESAHA.119.315715 PMid:33092464
Paschal BM, Shpetner HS, Vallee RB. MAP 1C is a microtubule- activated ATPase which translocates microtubules in vitro and has dynein-like properties. J Cell Biol. 1987;105(3):1273-82. https://doi.org/10.1083/JCB.105.3.1273 PMid:2958482
Hu C, Tian Y, Xu H, Pan B, Terpstra EM, Wu P, et al. Inadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury. J Clin Invest. 2018;128(12):5294-306. https://doi.org/10.1172/JCI98287 PMid:30204128
Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell. 2007;128(3):547-60. https://doi.org/10.1016/J.CELL.2006.12.037 PMid:17289573
Macquart C, Jüttner R, Rodriguez BM, Le Dour C, Lefebvre F, Chatzifrangkeskou M, et al. Microtubule cytoskeleton regulates connexin 43 localization and cardiac conduction in cardiomyopathy caused by mutation in A-type lamins gene. Hum Mol Genet. 2019;28(24):4043-52. https://doi.org/10.1093/HMG/DDY227 PMid:29893868
Smyth JW, Hong TT, Gao D, Vogan JM, Jensen BC, Fong TS, et al. Limited forward trafficking of connexin 43 reduces cell- cell coupling in stressed human and mouse myocardium. J Clin Invest. 2010;120(1):266-79. https://doi.org/10.1172/JCI39740 PMid:20038810
Denes LT, Kelley CP, Wang ET. Microtubule-based transport is essential to distribute RNA and nascent protein in skeletal muscle. Nat Commun. 2021;12(1):6079. https://doi.org/10.1038/S41467-021-26383-9 PMid:34707124
Robison P, Caporizzo MA, Ahmadzadeh H, Bogush AI, Chen CY, Margulies KB, et al. Detyrosinated microtubules buckle and bear load in contracting cardiomyocytes. Science. 2016;352(6284):aaf0659. https://doi.org/10.1126/science.aaf0659 PMid:27102488
Caporizzo MA, Chen CY, Salomon AK, Margulies KB, Prosser BL. Microtubules provide a viscoelastic resistance to myocyte motion. Biophys J. 2018;115(9):1796-807. https://doi.org/10.1016/J.BPJ.2018.09.019 PMid:30322798
Barmeyer A, Müllerleile K, Mortensen K, Meinertz T. Diastolic dysfunction in exercise and its role for exercise capacity. Heart Fail Rev. 2009;14(2):125-34. https://doi.org/10.1007/S10741-008-9105-Y PMid:18758943
Lin Z, Gasic I, Chandrasekaran V, Peters N, Shao S, Mitchison TJ, et al. TTC5 mediates autoregulation of tubulin via mRNA degradation. Science. 2020;367(6473):100-4. https://doi.org/10.1126/science.aaz4352 PMid:31727855
Li L, Zhang Q, Zhang X, Zhang J, Wang X, Ren J, et al. Microtubule associated protein 4 phosphorylation leads to pathological cardiac remodeling in mice. EBioMedicine. 2018;37:221-35. https://doi.org/10.1016/j.ebiom.2018.10.017 PMid:30327268
Yu X, Chen X,Amrute-Nayak M,Allgeyer E, ZhaoA, Chenoweth H, et al. MARK4 controls ischaemic heart failure through microtubule detyrosination. Nature. 2021;594(7864):560-5. https://doi.org/10.1038/s41586-021-03573-5 PMid:34040253
Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J. 2021:42(28):2745-60. https://doi.org/10.1093/eurheartj/ehab221 PMid:33961006
Fernández-Ruiz I. Targeting the cytoskeleton in heart failure. Nat Rev Cardiol. 2018;15:503. https://doi.org/10.1038/s41569-018-0056-2
Leung YY, Hui LL, Kraus VB. Colchicine--update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015;45(3):341-50. https://doi.org/10.1016/j.semarthrit.2015.06.013 PMid:26228647
Chaldakov GN. Colchicine, a microtubule-disassembling drug, in the therapy of cardiovascular diseases. Cell Biol Int. 2018;42(8):1079-84. https://doi.org/10.1002/cbin.10988 PMid:29762881
Fujisue K, Sugamura K, Kurokawa H, Matsubara J, Ishii M, Izumiya Y, et al. Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction. Circ J. 2017;81(8):1174-82. https://doi.org/10.1253/circj.CJ-16-0949 PMid:28420825
Robison P, Prosser BL. Microtubule mechanics in the working myocyte. J Physiol. 2017;595(12):3931-7. https://doi.org/10.1113/JP273046 PMid:28116814
Chen CY, Salomon AK, Caporizzo MA, Curry S, Kelly NA, Bedi K, et al. Depletion of vasohibin 1 speeds contraction and relaxation in failing human cardiomyocytes. Circ Res. 2020;127(2):e14-27. https://doi.org/10.1161/CIRCRESAHA.119.315947 PMid:32272864
Kerr JP, Robison P, Shi G, Bogush AI, Kempema AM, Hexum JK, et al. Detyrosinated microtubules modulate mechanotransduction in heart and skeletal muscle. Nat Commun. 2015;6:8526. https://doi.org/10.1038/ncomms9526 PMid:26446751
Curry EA 3rd, Murry DJ, Yoder C, Fife K, Armstrong V, Nakshatri H, et al. Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Invest New Drugs. 2004;22(3):299-305. https://doi. org/10.1023/B:DRUG.0000026256.38560.be PMid:15122077
Kurdi M, Bowers MC, Dado J, Booz GW. Parthenolide induces a distinct pattern of oxidative stress in cardiac myocytes. Free Radic Biol Med. 2007;42(4):474-81. https://doi.org/10.1016/j.freeradbiomed.2006.11.012 PMid:17275679